The gene encoding the cytoskeleton modulator DIAPH3 is lost frequently in metastatic prostate cancer, and DIAPH3 silencing induces a shift to an amoeba-like tumor phenotype in a variety of cellular settings. This evidence concerns the gene DIAPH3 and neoplasm.